Tim Willis and Oliver Wack outline the role of alternative data in supply chain risk management, and the ancillary benefits that come from adopting such technology.
Tim Willis and Oliver Wack
Advertisement
Tim Willis, is Director, Commercial Sales EMEA, at Dataminr, and Oliver Wack is Principal at Control Risks.
Articles by Tim Willis and Oliver Wack
Advertisement
Latest Updated Articles
Real-Time Information across the Pharma Supply ChainPublished: February 8th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
2
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
3
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
